Home › Funds › SEIZERT CAPITAL PARTNERS, LLC › REGN

SEIZERT CAPITAL PARTNERS, LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

SEIZERT CAPITAL PARTNERS, LLC reported holding 69,396 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$52.6M, representing 2.28% of its reported portfolio and ranking #14 among its reported holdings. SEIZERT CAPITAL PARTNERS, LLC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)69.40K sh
Reported value held$52.62M
Portfolio Weight2.28%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SEIZERT CAPITAL PARTNERS, LLC's REGN position evolved

SEIZERT CAPITAL PARTNERS, LLC first disclosed a stake in REGN in Q3 2023 at 58,795 shares (US$48.4M). The position peaked in Q4 2025 at 94,705 shares, worth US$73.1M. Across 13 filings, SEIZERT CAPITAL PARTNERS, LLC increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 69,396 shares valued at US$52.6M — a reduction of -1,773 shares quarter over quarter.. Notable position changes include a 52% increase in Q1 2025 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 58.80K $48.39M New
Q4 2023 55.77K $48.98M Reduce
Q1 2024 56.31K $54.20M Add
Q2 2024 51.96K $54.61M Reduce
Q3 2024 45.77K $48.12M Reduce
Q4 2024 54.30K $38.68M Add
Q1 2025 82.67K $52.43M Add
Q2 2025 85.98K $45.14M Add
Q3 2025 98.79K $55.55M Add
Q4 2025 94.70K $73.10M Reduce
Q1 2026 85.68K $66.20M Reduce
Q2 2026 71.17K $44.38M Reduce
Q3 2026 69.40K $52.62M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has SEIZERT CAPITAL PARTNERS, LLC held REGN?

SEIZERT CAPITAL PARTNERS, LLC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SEIZERT CAPITAL PARTNERS, LLC's current position in REGN?

As of Q3 2026, SEIZERT CAPITAL PARTNERS, LLC holds 69.40K shares of REGN (REGENERON PHARMACEUTICALS), valued at $52.62M, representing 2.28% of its reported portfolio and ranking #14.

Has SEIZERT CAPITAL PARTNERS, LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), SEIZERT CAPITAL PARTNERS, LLC reduced its position in REGN. The position peaked in Q4 2025 at 94.70K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.